G3X-21945-88901
3 vaccinations
4 coded responses
18 check-ins
4 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 208 / MD
- Registered
- 2020-12-29
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-29
Registered in v-safe
-
2020-12-29
Dose 1 — Pfizer-BioNTech
- 2020-12-29
-
2020-12-30
Survey response — days 1–6 daily, dose 1MedDRA: Adverse reaction — Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Have not felt this all day but during a period around 2 pm to 4ish. Temp check was at 2:30 pm. Only temp reading this farMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-30
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-05
- 2021-01-16
-
2021-01-21
Dose 2 — Pfizer-BioNTech
- 2021-01-26
- 2021-01-28
- 2021-02-04
- 2021-02-11
- 2021-02-18
-
2021-02-27
Survey response — day 35, dose 2MedDRA: Fatigue, Muscle spasms, Muscle twitching, Paraesthesia — Feeling: Fair · Be unable to workFree text: Extreme fatigue with tingling/twitching extremities and muscle spasms.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-04
-
2021-04-22
Survey response — 3 months, dose 2MedDRA: Asthenia, Dizziness, Fatigue, Office visit — Feeling: Fair · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Symptoms: Occasional recurring Extreme fatigue with weakness and lightheaded ness/dizziness. · Healthcare visit (other): Visit to primary care and rheumatologist.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-22
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-08
-
2021-07-24
Survey response — 6 months, dose 2MedDRA: Cardiolipin antibody positive, Fatigue, Fibrin D dimer increased, Malaise, Musculoskeletal stiffness, Pain in extremity, Self-medication, Unevaluable event — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Symptoms: Pain, often excruciating, in legs (especially left) in foot and arms. Periods of extreme fatigue. Stiffness in hands and toes. Doesnt respond to pain meds or heat. Elevated anticardiolipin Ab IgM and d dimer. Not feeling well. · Healthcare visit (other): Scheduling follow up with primary care docMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-24
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-07-29
-
2021-10-05
Dose 3 — Pfizer-BioNTech
- 2022-01-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-29 | Pfizer-BioNTech | |
| 2 | 2021-01-21 | Pfizer-BioNTech | |
| 3 | 2021-10-05 | Pfizer-BioNTech | No |
Call center
3 call center cases
2 unsuccessful · 1 priority 2/3 (triaged and no follow up)
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Have not felt this all day but during a period around 2 pm to 4ish. Temp check was at 2:30 pm. Only temp reading this far
Release 4 — day 35, dose 2
Symptoms: Extreme fatigue with tingling/twitching extremities and muscle spasms.
Release 7 — 3 months, dose 2
Symptoms: Occasional recurring Extreme fatigue with weakness and lightheaded ness/dizziness.
Healthcare visit (other): Visit to primary care and rheumatologist.
Release 9 — 6 months, dose 2
Symptoms: Pain, often excruciating, in legs (especially left) in foot and arms. Periods of extreme fatigue. Stiffness in hands and toes. Doesnt respond to pain meds or heat. Elevated anticardiolipin Ab IgM and d dimer. Not feeling well.
Healthcare visit (other): Scheduling follow up with primary care doc
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| HCVO | Unevaluable event | ✓ | · | ✓ |
| SD | Asthenia | ✓ | ✓ | ✓ |
| SD | Cardiolipin antibody positive | ✓ | · | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Fibrin D dimer increased | ✓ | · | ✓ |
| SD | Malaise | ✓ | · | ✓ |
| SD | Muscle spasms | ✓ | ✓ | ✓ |
| SD | Muscle twitching | ✓ | ✓ | ✓ |
| SD | Musculoskeletal stiffness | ✓ | · | ✓ |
| SD | Pain in extremity | ✓ | · | ✓ |
| SD | Paraesthesia | ✓ | ✓ | ✓ |
| SD | Self-medication | ✓ | · | ✓ |
| SRO | Adverse reaction | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release